share_log

BMO Capital Maintains Outperform on Aptinyx, Lowers Price Target to $2

BMO Capital Maintains Outperform on Aptinyx, Lowers Price Target to $2

BMO Capital在Aptinyx上保持跑赢大盘,将目标股价下调至2美元
Benzinga Real-time News ·  2022/08/15 09:16

BMO Capital analyst Gary Nachman maintains Aptinyx (NASDAQ:APTX) with a Outperform and lowers the price target from $6 to $2.

BMO Capital分析师加里·纳赫曼维持Aptinyx(纳斯达克股票代码:APTX)跑赢大盘,并将目标股价从6美元下调至2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发